These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. Yanase DJ, David-Bajar K. J Am Acad Dermatol; 2001 Jan; 44(1):89-93. PubMed ID: 11148482 [Abstract] [Full Text] [Related]
10. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. van Ophoven A, Pokupic S, Heinecke A, Hertle L. J Urol; 2004 Aug; 172(2):533-6. PubMed ID: 15247722 [Abstract] [Full Text] [Related]
11. Treatment of interstitial cystitis with montelukast, a leukotriene D(4) receptor antagonist. Bouchelouche K, Nordling J, Hald T, Bouchelouche P. Urology; 2001 Jun; 57(6 Suppl 1):118. PubMed ID: 11378098 [No Abstract] [Full Text] [Related]
12. Bladder pain syndrome/interstitial cystitis in a Danish population: a study using the 2008 criteria of the European Society for the Study of Interstitial Cystitis. Richter B, Hesse U, Hansen AB, Horn T, Mortensen SO, Nordling J. BJU Int; 2010 Mar; 105(5):660-7. PubMed ID: 19751261 [Abstract] [Full Text] [Related]
16. Brief case series: montelukast, at doses recommended for asthma treatment, reduces disease severity and increases soluble CD14 in children with atopic dermatitis. Hon KL, Leung TF, Ma KC, Wong Y, Fok TF. J Dermatolog Treat; 2005 Feb; 16(1):15-8. PubMed ID: 15897161 [Abstract] [Full Text] [Related]
17. Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis. Hwang P, Auclair B, Beechinor D, Diment M, Einarson TR. Urology; 1997 Jul; 50(1):39-43. PubMed ID: 9218016 [Abstract] [Full Text] [Related]